TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
NCT05544149
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
42
Enrollment
OTHER
Sponsor class
Conditions
SCLC,Extensive Stage
Interventions
RADIATION:
Thoracic radiotherapy
Sponsor
Zhejiang Cancer Hospital